| Literature DB >> 33410196 |
Alexander Zimmermann1, Qais Z Jaber2, Johannes Koch3, Steffen Riebe1, Cecilia Vallet4, Kateryna Loza5, Matthias Hayduk1, Kfir B Steinbuch2, Shirley K Knauer4, Micha Fridman2, Jens Voskuhl1.
Abstract
We report the characterization of amphiphilic aminoglycoside conjugates containing luminophores with aggregation-induced emission properties as transfection reagents. These inherently luminescent transfection vectors are capable of binding plasmid DNA through electrostatic interactions; this binding results in an emission "on" signal due to restriction of intramolecular motion of the luminophore core. The luminescent cationic amphiphiles effectively transferred plasmid DNA into mammalian cells (HeLa, HEK 293T), as proven by expression of a red fluorescent protein marker. The morphologies of the aggregates were investigated by microscopy as well as ζ-potential and dynamic light-scattering measurements. The transfection efficiencies using luminescent cationic amphiphiles were similar to that of the gold-standard transfection reagent Lipofectamine® 2000.Entities:
Keywords: aggregation-induced emission; bioimaging; cationic amphiphiles; self-assembly; transfection agents
Mesh:
Substances:
Year: 2021 PMID: 33410196 PMCID: PMC8248372 DOI: 10.1002/cbic.202000725
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164
Figure 1Molecular structure of luminescent amphiphilic tobramycins 1 and 2. The AIE‐active part of the molecule is shown in turquoise.
Figure 2A) Increase in optical density upon the addition of plasmid DNA at 500 nm as determined by UV/Vis spectroscopy, concentration 1=2=100 μM, concentration (plasmid)=10 μg/mL, measured in triplicate. B) AFM and STEM images of 1 and 2 in the presence of plasmid DNA, concentrations as in (A). Emission enhancement upon the addition of different concentrations of plasmid DNA to C) 1 or D) 2 (50 μM), E) Photographs of 1 and 2 in the presence and absence of plasmid DNA, concentration of 1=2=50 μM under UV‐light excitation (λ ex=365 nm). F) ζ‐Potential changes upon the addition of plasmid DNA to a fixed concentration (100 μM) of 1 and 2 versus the ratio of negative and positive (N/P) charges in the system and the concentration of plasmid DNA (for calculation details please see the Supporting Information), Samples of compound 1 and 2 were prepared from DMSO stock solutions (40 mM).
Figure 3Microscopy images (CLSM) of HEK 293T and HeLa cells 16 h after transfection with 2 (47.6 μM, turqoise) premixed with pH2B‐mRFP plasmid (2.4 μg/mL, red). Scale bars: 100 μm, for details see the Supporting Information. Compound 2 was added from a stock solution in DMSO (40 mM).
Figure 4A) Cell viability (MTS cell proliferation assay) of HeLa cells with different concentrations of 1 and 2. B) Transfection efficiency of 1 and 2 for HeLa and HEK 293T cells. Concentration 1=2=47.6 μM, [pH2B‐mRFP plasmid]=2.4 μg/mL. Lipofectamine® 2000 is shown for comparison. Volume (Lipofectamine® 2000)=1 μL, [pH2B‐mRFP plasmid]=500 ng/50 μL medium. Compounds 1 and 2 were added from stock solutions in DMSO (40 mM).
Figure 5Microscopy images (CLSM) of HeLa cells 2 and 24 h after transfection with 2 (47.6 μM, dark blue) premixed with pH2B‐mRFP plasmid (2.4 μg/mL, red) and stained with LysoTracker™ Green. Scale bar: 20 μm, for details see the Supporting Information. Compound 2 was added from a stock solution in DMSO (40 mM).